Brivanib versus sorafenib as first-line therapy in patients with unresectable, advanced hepatocellular carcinoma: results from the randomized phase III BRISK-FL study
| Image |  |
|---|---|
| Description | scientific article published on 26 August 2013 |
| Author/s |
author: Abhasnee Sobhonslidsuk Masatoshi Kudo |
| Publication date | August 26, 2013 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |